PROKARYOTICS

Prokaryotics Inc. is an authentic antibacterial discovery organization committed to bringing forth innovative therapeutics to address the problem of multidrug resistant bacteria and combating the emerging global crisis of antibiotic resistance... We are a start-up company resulting from the licensing of several novel antibiotic programs from Merck & Co., Inc. - by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck's early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria... At Prokaryotics Inc., we have assembled a world class team of industry experts, academic leaders, and innovative proprietary assets to develop next generation antibiotics to combat this crisis. Each of our Prokaryotics antibiotic development programs uniquely target distinct cell..

Also known as: Prokaryotics Inc.

Primary location: Union United States